Home › Bronchogenic Carcinoma
Bronchogenic Carcinoma clinical trials recruiting in the U.S.
5 studies for Bronchogenic Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
- California4 studies
- Florida3 studies
- Illinois3 studies
- Massachusetts3 studies
- Ohio3 studies
- Texas3 studies
Recently updated studies
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recruiting
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT02984761A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT06623656From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.